Daivonex 0.005% ointment 30 g,Daivonex 0,005% unguento 30 g,Leo laboratories Limited

“The product is based on the active ingredient calcipotriol, an analogue of vitamin D3.
Daivonex makes it possible to control psoriasis without the use of hormones and live a full life.
Daivonex is specifically designed to treat psoriasis vulgaris, but it also helps keep psoriasis free of relapse after a course of any topical steroid.
Calcitriol:
Reduces the rate of skin cell division
Improves cell maturation
Slightly penetrates the skin
Virtually no effect on calcium metabolism
Reduces the risk of skin atrophy caused by betamethasone
The overall effectiveness of Calcipotriol is comparable to that of a combination product containing a strong steroid and salicylic acid, having a similar exfoliating effect.
Daivonex is a proven non-hormonal alternative to treating psoriasis, without the side effects of and salicylic acid.
Application:
The drug is applied to the affected areas in a thin layer 1 or 2 times a day.
Open the bottle, apply the ointment, spread and rub the ointment in with your fingertips.
Be sure to wash your hands after applying the ointment.
Duration of treatment:
Treatment usually lasts 6-8 weeks, but can be continued as directed by your doctor.
Advantages:
Free from the side effects of .
Its effectiveness from the standpoint of evidence-based medicine has been confirmed by numerous clinical studies (used for 15 years).
Affects all parts of the pathogenesis of psoriasis.
Possibility of combination with other methods of treating psoriasis.
A variety of forms – ointment, cream, solution – for any localization of the skin process.
Excellent cosmetic properties (odorless, colorless, does not stain clothes or skin).
Side effect:
Most typical: local skin irritation.
Typical: erythema and itching of the skin.
Atypical: dermatitis (including facial and perioral dermatitis when using the solution); exacerbation of psoriasis.
Very rare: hyperpigmentation; hypercalciuria; hypercalcemia.
Overdose:
Use of the drug in doses exceeding the recommended ones may cause an increase in the concentration of calcium in the blood. In this case, treatment should be stopped.
Interaction:
Daivonex should not be used with topical medications containing salicylic acid.
Special instructions:
Before use, you should consult your doctor.
It is not recommended to apply Dayvonex to the face. To avoid contact of the drug with the skin of the face, hands should be washed thoroughly after each use. Hypercalcemia develops when the maximum dose of calcipotriol per week is exceeded. When the drug is discontinued, the concentration of calcium in the blood quickly normalizes.
It should be noted that the total dose of calcipotriol should not exceed 5 mg per week.
The prescription of Daivonex ointment and cream can be combined with PUVA therapy.
There is no effect on the ability to drive a car or drive machinery.
Storage:
Store at a temperature not exceeding 25°C, out of the reach of children.
Packaging: tube 30 g”